Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Neuroactive flavonoids interacting with GABAA receptor complex.

Feng Wang1, Michael Shing, Yan Huen

  • 1Department of Biochemistry, Hong Kong University of Science and Technology, Clear Water Bay, Kowloon, Hong Kong.

Current Drug Targets. CNS and Neurological Disorders
|November 4, 2005
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Experimental study on targeted methotrexate delivery to the rabbit brain via magnetic resonance imaging-guided focused ultrasound.

Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine·2009
Same author

Comparison of lung scintigraphy with multi-slice spiral computed tomography in the diagnosis of pulmonary embolism.

Clinical nuclear medicine·2009
Same author

[Analysis on the characters of injuries in body surface and deduction of injury-causing instruments in 146 cases].

Fa yi xue za zhi·2009
Same author

Impact of ketone and amino on the inner shell of guanine.

Journal of synchrotron radiation·2009
Same author

Actin turnover is required for myosin-dependent mitochondrial movements in Arabidopsis root hairs.

PloS one·2009
Same author

Direct observation of a widely tunable bandgap in bilayer graphene.

Nature·2009

Flavonoids, natural compounds from medicinal herbs, show promise as alternatives to benzodiazepines for CNS disorders. They bind to GABAA receptors with fewer side effects, offering a new therapeutic avenue.

Area of Science:

  • Neuropharmacology
  • Medicinal Chemistry
  • Natural Products

Background:

  • Classical benzodiazepines (BZs) are widely used CNS drugs targeting GABAA receptors but have significant side effects.
  • Research seeks novel BZ-site ligands with improved therapeutic profiles and reduced adverse effects.
  • Flavonoids, found in medicinal herbs, possess moderate binding affinity for the BZ-site.

Purpose of the Study:

  • To review the potential of flavonoids as therapeutic agents for GABAA receptor-mediated disorders.
  • To summarize structure-activity relationships (SAR) guiding the development of effective flavonoid ligands.

Main Methods:

  • Analysis of in vivo and in vitro studies on flavonoid binding to the BZ-site of GABAA receptors.
  • Review of structure-activity relationship (SAR) studies, including modifications to the flavone backbone (C6, C3') and critical moieties (2'-hydroxyl).

Related Experiment Videos

  • Examination of pharmacophore models derived from quantitative SAR studies.

    • Main Results:

    • Flavonoids act as partial agonists or antagonists at GABAA receptors.
    • Anxiolytic effects of partial agonistic flavonoids occur without typical sedative and myorelaxant side effects.
    • Specific structural modifications (electronegative groups at C6/C3', 2'-hydroxyl) enhance BZ-site binding affinity.

    Conclusions:

    • Flavonoids demonstrate significant potential as novel therapeutics for CNS disorders.
    • Synthetic flavonoids with high binding affinity and in vivo activity have been developed based on SAR.
    • Flavonoids represent a promising class of compounds for treating GABAA receptor-mediated conditions.